SD
Santosh Datta Naik
About Santosh Datta Naik
Data last updated:
Santosh Datta Naik is a Director at Cdymax (India) Pharma Private Limited (since 2024). The company operates in Pharma. Cdymax (India) Pharma Private Limited reported revenue of ₹285 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cdymax (India) Pharma Private Limited U85110KA1994PTC016472 | Director | 08 Jan 2024 | 1994 | ₹285 Cr (FY 2025) | Active |
Board colleagues of Santosh Datta Naik
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manorama Avinash | 03457332 | Cdymax (India) Pharma Private Limited | Director |
| Siri Surendra Bhat | Cdymax (India) Pharma Private Limited | Company Secretary |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Santosh Datta Naik
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Santosh Datta Naik
Santosh Datta Naik currently holds 1 directorship: Cdymax (India) Pharma Private Limited (Director, since 08 Jan 2024, revenue ₹285 Cr (FY 2025)).
Santosh Datta Naik was first appointed on 08 Jan 2024 as Director at Cdymax (India) Pharma Private Limited.
The current boards of Santosh Datta Naik's companies include Manorama Avinash (Cdymax (India) Pharma Private Limited), Siri Surendra Bhat (Cdymax (India) Pharma Private Limited).